These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17690249)

  • 41. Inter-Individual Variation in Response to Estrogen in Human Breast Explants.
    Dunphy KA; Black AL; Roberts AL; Sharma A; Li Z; Suresh S; Browne EP; Arcaro KF; Ser-Dolansky J; Bigelow C; Troester MA; Schneider SS; Makari-Judson G; Crisi GM; Jerry DJ
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):51-68. PubMed ID: 32152951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.
    Knopfová L; Biglieri E; Volodko N; Masařík M; Hermanová M; Glaus Garzón JF; Dúcka M; Kučírková T; Souček K; Šmarda J; Beneš P; Borsig L
    Oncogene; 2018 Feb; 37(8):1020-1030. PubMed ID: 29084208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival.
    Nicolau M; Levine AJ; Carlsson G
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7265-70. PubMed ID: 21482760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells.
    Chen L; Xu S; Zeng X; Li J; Yin W; Chen Y; Shao Z; Jin W
    Acta Biochim Biophys Sin (Shanghai); 2010 Jan; 42(1):1-7. PubMed ID: 20043041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis.
    Knopfová L; Beneš P; Pekarčíková L; Hermanová M; Masařík M; Pernicová Z; Souček K; Smarda J
    Mol Cancer; 2012 Mar; 11():15. PubMed ID: 22439866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of estrogen receptor in breast cancer cell gene expression.
    Zheng Y; Shao X; Huang Y; Shi L; Chen B; Wang X; Yang H; Chen Z; Zhang X
    Mol Med Rep; 2016 May; 13(5):4046-50. PubMed ID: 27035558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.
    Kinyamu HK; Collins JB; Grissom SF; Hebbar PB; Archer TK
    Mol Carcinog; 2008 Nov; 47(11):845-85. PubMed ID: 18381591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.
    Dong XY; Guo P; Sun X; Li Q; Dong JT
    J Biol Chem; 2011 Apr; 286(16):13879-90. PubMed ID: 21367855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.
    Azim S; Zubair H; Srivastava SK; Bhardwaj A; Zubair A; Ahmad A; Singh S; Khushman M; Singh AP
    Sci Rep; 2016 Jun; 6():28446. PubMed ID: 27354262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
    Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
    Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells.
    Dúcka M; Kučeríková M; Trčka F; Červinka J; Biglieri E; Šmarda J; Borsig L; Beneš P; Knopfová L
    Neoplasia; 2021 Mar; 23(3):326-336. PubMed ID: 33621853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen-estrogen receptor signaling suppresses the transcription of ERRF in breast cancer cells.
    Luo A; Su D; Zhang X; Qi L; Fu L; Dong JT
    J Genet Genomics; 2016 Sep; 43(9):565-567. PubMed ID: 27599921
    [No Abstract]   [Full Text] [Related]  

  • 53. Targeting c-Myb expression in human disease.
    Ramsay RG; Barton AL; Gonda TJ
    Expert Opin Ther Targets; 2003 Apr; 7(2):235-48. PubMed ID: 12667100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
    Chimge NO; Ahmed-Alnassar S; Frenkel B
    Cell Cycle; 2017 Feb; 16(4):312-318. PubMed ID: 28055379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-MYB and DMTF1 in Cancer.
    Fry EA; Inoue K
    Cancer Invest; 2019; 37(1):46-65. PubMed ID: 30599775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nemo-like kinase associated with proliferation and apoptosis by c-Myb degradation in breast cancer.
    Huang Y; Jiang Y; Lu W; Zhang Y
    PLoS One; 2013; 8(7):e69148. PubMed ID: 23935942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.
    Liu LY; Chang LY; Kuo WH; Hwa HL; Chang KJ; Hsieh FJ
    Comput Math Methods Med; 2014; 2014():813067. PubMed ID: 24639887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-MYB and TGFβ: EMT's dynamic duo in breast cancer.
    Sala A
    Cell Cycle; 2012 Jan; 11(1):17. PubMed ID: 22186784
    [No Abstract]   [Full Text] [Related]  

  • 59. Cells transformed by a v-Myb-estrogen receptor fusion differentiate into multinucleated giant cells.
    Engelke U; Wang DM; Lipsick JS
    J Virol; 1997 May; 71(5):3760-6. PubMed ID: 9094651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myb: getting involved in EMT.
    Ramsay R
    Cell Cycle; 2012 Feb; 11(3):433-4. PubMed ID: 22293402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.